Mauna Kea, Cook Medical terminate Cellvizio dev, distro deal
Mauna Kea (ENT:MKEA) said today that it and Cook Medical have mutually decided to terminate their development and distribution agreement. The deal, originally inked in late 2015, included the development of Mauna Kea’s Cellvizio confocal laser endomicroscopy systems for urologic applications. Paris-based Mauna Kea said that it agreed to develop a private-label version of the Cellvizio with an emphasis on characterizing upper urinary tract urothelial cancer. “Mauna Kea was understandably excited by the prospect of combining our innovative, confocal laser endomicroscopy technology with an established medical...
Source: Mass Device - February 21, 2019 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Featured Imaging Urology Cook Medical Mauna Kea Technologies Source Type: news

Single vs Multiport Lap Colectomy: Only Benefit Cosmetic? Single vs Multiport Lap Colectomy: Only Benefit Cosmetic?
Dr Lowenfels comments on a study that compares the outcomes of single-incision and multiport laparoscopy for colonic surgery.Medscape General Surgery (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - February 19, 2019 Category: Consumer Health News Tags: General Surgery Viewpoint Source Type: news

Laparoscopic Gastrectomy Outcome Comparable to Open Surgery Laparoscopic Gastrectomy Outcome Comparable to Open Surgery
Patients with stage I gastric cancer who undergo laparoscopic distal gastrectomy have long-term-survival rates similar to those who have open distal gastrectomy, according to a clinical trial from South Korea.Reuters Health Information (Source: Medscape General Surgery Headlines)
Source: Medscape General Surgery Headlines - February 15, 2019 Category: Surgery Tags: General Surgery News Source Type: news

ConMed closes $365m Buffalo Filter buy
ConMed (NSDQ:CNMD) said today that it closed its $365 million acquisition of Buffalo Filter from the Filtration Group. Buffalo Filter develops and produces surgical smoke evacuation technologies, including smoke evacuation pencils, smoke evacuators and laparoscopic solutions, ConMed said. Utica, N.Y.-based ConMed said that it funded the transaction through a combination of convertible notes and an expanded and amended credit facility. Last month, ConMed priced a debt offering worth $300 million, saying it plans to use the proceeds to pay down some of its hedges and to cover the cost of an acquisition. The post Co...
Source: Mass Device - February 12, 2019 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Mergers & Acquisitions Wall Street Beat ConMed Corp. Source Type: news

Laparoscopic Is Best for Inguinal Hernia Repair in Females Laparoscopic Is Best for Inguinal Hernia Repair in Females
Laparoscopic versus open repair of inguinal hernia in women: which has lower recurrence rates? Dr Lowenfels comments on a recent study published in JAMA Surgery.Medscape General Surgery (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - February 12, 2019 Category: Consumer Health News Tags: General Surgery Viewpoint Source Type: news

Laparoscopic Surgery for Crohn's More Cost-Effective Than Infliximab (CME/CE)
(MedPage Today) -- More QALYs gained, 1-year health-related costs less (Source: MedPage Today Surgery)
Source: MedPage Today Surgery - February 10, 2019 Category: Surgery Source Type: news

Outcome of kidney function after ischaemic and zero-ischaemic laparoscopic and open nephron-sparing surgery for renal cell cancer
Nephron-sparing surgery (NSS) remains gold standard for the treatment of localised renal cell cancer (RCC), even in the case of a normal contralateral kidney.02/08/2019 (Source: Kidney Cancer Association)
Source: Kidney Cancer Association - February 8, 2019 Category: Urology & Nephrology Source Type: news

Laparoscopic Resection in Crohn's More Cost-Effective Than Infliximab
(MedPage Today) -- More QALYs gained and 1-year health costs were $10,000 less in European study (Source: MedPage Today Gastroenterology)
Source: MedPage Today Gastroenterology - February 5, 2019 Category: Gastroenterology Source Type: news

Laparoscopic Whipple Procedure Linked to More Deadly Complications
(MedPage Today) -- Also, no reduction in recovery or hospitalization time versus open pancreatoduodenectomy (Source: MedPage Today Gastroenterology)
Source: MedPage Today Gastroenterology - January 26, 2019 Category: Gastroenterology Source Type: news

CO2 Pneumothorax Following Laparoscopic Partial Nephrectomy CO2 Pneumothorax Following Laparoscopic Partial Nephrectomy
This case highlights the awareness and therapeutic choice of noninvasive management for capno-thorax, an uncommon but potentially serious complication of laparoscopic surgery.BMC Anesthesiology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - January 23, 2019 Category: Consumer Health News Tags: Anesthesiology Journal Article Source Type: news

Repeat Tubal Procedures Up After Hysteroscopic Sterilization
TUESDAY, Jan. 22, 2019 -- Hysteroscopic sterilization is associated with an increased risk for additional tubal intervention within seven years compared with laparoscopic sterilization, according to a study published online Jan. 8 in Obstetrics... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 22, 2019 Category: Pharmaceuticals Source Type: news

JustRight Surgical rebrands to Bolder Surgical, raises $27m
Bolder Surgical, formerly known as JustRight Surgical, said today that it raised $27 million in a new round of financing to support its laparoscopic surgical devices. The round was led by River City Capital Funds and joined by Westwood Management, Providence Ventures and previous investors, the Louisville, Colo.-based company said. Funds raised in the round will support the company’s product innovation pipeline, increases in workforce and scaling commercialization. In connection with the round, Westwood Management managing partner Lair Kennedy and River Cities Capital managing partner Carter McNabb will join the comp...
Source: Mass Device - January 16, 2019 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Featured Surgical JustRight Surgical Source Type: news

TransEnterix wins FDA clearance for Senhance Ultrasonic
TransEnterix (NYSE:TRXC) said today that it won 510(k) clearance from the FDA for its Senhance Ultrasonic instrument system, designed to operate with its Senhance robot-assisted surgery device. Senhance Ultrasonic instruments are designed to deliver controlled energy to ligate and divide tissue and minimize thermal injury to surrounding structures, Research Triangle Park, N.C.-based TransEnterix said. The instrument set is now on the market in the U.S. and all countries that recognize the CE Mark, which the company won for Senhance Ultrasonic last October. The U.S. clearance for Senhance covers lap...
Source: Mass Device - January 15, 2019 Category: Medical Devices Authors: Brad Perriello Tags: Featured Food & Drug Administration (FDA) Regulatory/Compliance Robotics TransEnterix Source Type: news

Essure Discontinuation Doesn & #039;t Mean the End to FDA Scrutiny
FDA wants the public to know it is taking steps to make sure the long-term safety profile of a controversial birth control device continues to be studied even after U.S. sales of the device are discontinued at the end of the year. While this seems like a good idea, in theory, patient advocates have concerns about the validity and feasibility of the required post-market study. Bayer announced in July that it would stop selling the Essure device at the end of the year due to a decline in U.S. sales. FDA Commissioner Scott Gottlieb said at the time that the agency would still hold the compa...
Source: MDDI - December 20, 2018 Category: Medical Devices Authors: Amanda Pedersen Tags: Regulatory and Compliance Source Type: news

National Bowel Cancer Audit: annual report 2018
This ninth annual report from the National Bowel Cancer Audit examines data on over 30,000 patients diagnosed with bowel cancer between 01 April 2016 and 31 March 2017. It describes some ongoing improvements such as mortality rates following both elective and emergency surgery falling over the past five years and increased numbers of operations being performed laparoscopically. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - December 19, 2018 Category: Consumer Health News Source Type: news

Operating Rooms Get a Dose of Augmented Reality
Operating rooms are set to get a dose of augmented reality because of a new clearance from FDA. The agency recently signed off on an augmented surgical navigation system from Mariner Endosurgery. The Ontario-based company’s LaparoGuard is an augmented surgical navigation system that enables surgeons to annotate areas of 3D safety zones during minimally invasive procedures, to aid surgeons in guiding their tools and informing their surgical approach. Similar to the heads-up display of a fighter jet, LaparoGuard allows surgeons to annotate areas of risk, and then see 3D renderings of surgeon-defined safety ...
Source: MDDI - December 15, 2018 Category: Medical Devices Authors: Omar Ford Tags: Regulatory and Compliance Imaging Source Type: news

ConMed to acquire Buffalo Filter for $365m
ConMed (NSDQ:CNMD) said today that it inked a deal to acquire surgical smoke evacuation tech developer Buffalo Filter for $365 million. Buffalo Filter develops and produces surgical smoke evacuation technologies, including smoke evacuation pencils, smoke evacuators and laparoscopic solutions, ConMed said. Utica, N.Y.-based ConMed said that it expects to finance the transaction through a combination of new convertible notes and an expanded and amended credit facility. ConMed expects the acquisition to close in the first quarter of next year. “We are excited to join ConMed and continue our mission of improving saf...
Source: Mass Device - December 13, 2018 Category: Medical Devices Authors: Fink Densford Tags: Featured Mergers & Acquisitions Surgical ConMed Corp. Source Type: news

Surgeon Experience and Medicare Expenditures for Colectomy Surgeon Experience and Medicare Expenditures for Colectomy
How do Medicare payments for laparoscopic and open colectomy compare? Might a surgeon's experience impact payment?Annals of Surgery (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - December 10, 2018 Category: Consumer Health News Tags: General Surgery Journal Article Source Type: news

Olympus wins FDA nod for Spiration bronchial valve
Olympus (TYO:7733) said yesterday that it won FDA approval for its Spiration Valve System intended to treat severe emphysema, which was designated as a breakthrough medical device. The Spiration Valve is an umbrella shaped device intended to improve breathing by blocking airflow to diseased portions of the lung, the Tokyo-based company said. The device is placed during a bronchoscopic procedure to reduce lung volume in diseased lung sections and allow healthier tissue in the remaining portion of the lung to function better. Approval of the device came based on the results from the Emprove clinical trial of the SV...
Source: Mass Device - December 6, 2018 Category: Medical Devices Authors: Fink Densford Tags: Food & Drug Administration (FDA) Regulatory/Compliance Respiratory Olympus Source Type: news

Imaging dev Lightpoint Medical raises $6m
Medical imaging dev Lightpoint Medical said today it raised approximately $6.4 million (GBP £5 million) in a new financing round slated to support the commercialization of the company’s robotic laparoscopic probe and its LightPath imaging system. Money in the round came from Cambridge Capital Group, Venture Founders, Coutts Investment Club, Envestors, Fund Twenty8, SyndicateRoom and Oxford Technology, the Chesham, U.K.-based company said. It added that it has also raised more than $3.8 million (GBP £3 million) from Horizon 2020 SME instrument and Innovate UK. “We are very proud to have supporte...
Source: Mass Device - December 6, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Imaging lightpointmedical Source Type: news

TIGR(R)Matrix shows promising results when used for incisional hernia prevention in septic patients undergoing laparoscopy
UPPSALA, Sweden, Dec. 4, 2018 -- (Healthcare Sales & Marketing Network) -- Onlay mesh placement of the synthetic and fully resorbable TIGR®Matrix surgical mesh (Novus Scientific AB, Uppsala -- Sweden) for the prevention of incisional hernia in septic ... Devices, Surgery Novus Scientific, TIGR Matrix, surgical mesh, laparoscopy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - December 4, 2018 Category: Pharmaceuticals Source Type: news

Upper GI X-rays Unhelpful After Sleeve Gastrectomy Upper GI X-rays Unhelpful After Sleeve Gastrectomy
Gastrografin upper gastrointestinal inspection is generally of little value in determining the integrity of staple lines following laparoscopic sleeve gastrectomy, according to a retrospective review.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 13, 2018 Category: Consumer Health News Tags: General Surgery News Source Type: news

Medtronic backs infant-sized miniature pacer
Medtronic (NYSE:MDT) is collaborating with researchers at the Children’s National Health System to develop a miniature pacemaker intended for use with infants. The prototype version of the device was presented at the American Heart Association’s 2018 Scientific Sessions by Dr. Rohan Kumthekar of the Sheikh Zayed Institute for Pediatric Surgical Innovation, part of the Children’s National Health System. The newly developed miniature pacer is designed to be implanted through a 1 cm incision just below the ribcage, eliminating the need for open-chest surgery, according to a CNHS report. The device is im...
Source: Mass Device - November 13, 2018 Category: Medical Devices Authors: Fink Densford Tags: Cardiac Assist Devices Cardiac Implants Cardiovascular Research & Development Medtronic Source Type: news

TransEnterix posts Street-beating Q3
TransEnterix (NYSE:TRXC) today posted third quarter earnings that beat expectations on Wall Street. The Research Triangle Park, N.C.-based company posted losses of $20.2 million, or 10¢ per share, on sales of $5.4 million for the three months ended September 30, seeing losses shrink 47.5% while sales grew nearly 3000% compared with the same period during the previous year Adjusted to exclude one-time items, losses per share were 6¢, just ahead of the 7¢ loss-per-share consensus on Wall Street where analysts expected to see sales of $5.3 million, which TransEnterix topped. “We are proud of the prog...
Source: Mass Device - November 8, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Featured MassDevice Earnings Roundup Wall Street Beat TransEnterix Source Type: news

Eximis Working on a New Surgical Platform
Eximis Surgical has secured $7.5 million in financing to help develop a surgical platform for the removal large specimens through small laparoscopic incisions. The financing was led by Questa Capital with participation from Venture Investors. The Louisville, CO-based company said it will use the new capital to fund U.S. regulatory approval and the commercial launch of the Eximis Laparoscopic Specimen Removal System. The firm said its platform uses specimen removal technique to have multiple, integrated containment bags for increased confidence and a novel cutting technology that eliminates the need for sharps during segmen...
Source: MDDI - November 8, 2018 Category: Medical Devices Authors: Omar Ford Tags: Business Source Type: news

Surgical Robotics Market Due for a Shake Up?
For years, Intuitive has been recognized as the leader of the surgical robotics market. But there are more competitors on the horizon and the entry level for the surgical robotics’ market is far easier than it used to be. Roger Smith, MD, the Chief Technology Officer for the Florida Hospital Nicholson Center, spoke with MD+DI about the state of the surgical robotics market and what could possibly lie ahead for the space. “When you look at the volume of procedures that are conducted with devices that are considered robotic, probably 70% are conducted with da Vinci,” Smit...
Source: MDDI - November 5, 2018 Category: Medical Devices Authors: Omar Ford Tags: Business Source Type: news

Acessa Health launches third-gen Acessa ProVu system
Acessa Health said today that it launched its third-generation Acessa ProVu system intended to treat uterine fibroid tumors with minimally-invasive laparoscopic radiofrequency ablation in the U.S. The Austin, Texas-based company added that the system has been used in its first procedures in the U.S. “I’ve used every generation of the Acessa family of products and can say, with certainty, that after using Acessa ProVu, the system has reached a pinnacle of technological innovation. The Acessa ProVu system is going to allow more physicians to offer this treatment to their patients and I’m excited to be part ...
Source: Mass Device - November 2, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Featured acessahealth Source Type: news

Laparoscopic surgery for cervical cancer led to higher risk of death, study shows
New research with alarming results is changing the way doctors treat cervical cancer. Laparoscopic surgery is a less invasive procedure that involves a small incision in the abdomen, but it led to a higher risk of death from cervical cancer, compared with patients who had a traditional hysterectomy. Dr. David Agus joins "CBS This Morning" from Los Angeles to discuss the concerns. (Source: Health News: CBSNews.com)
Source: Health News: CBSNews.com - November 1, 2018 Category: Consumer Health News Source Type: news

Minimally Invasive Surgery Is Standard for Cervical Cancer. But A New Study Shows It ’s Not Effective
In a demonstration that newer isn’t always better, two studies published in the New England Journal of Medicine show that minimally invasive surgery techniques, including robotic surgery, lead to higher death rates from any cause than traditional, open surgery done through an incision in the abdomen. Minimally invasive surgery — or keyhole surgery, in which doctors perform operations through small incisions rather than by opening up patients and exposing them to complications — and robotic surgery have shortened recovery times and cut back on infections and bleeding. So in many cases, surgeons prefer usin...
Source: TIME: Health - October 31, 2018 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized Cancer healthytime Source Type: news

Laparoscopic Cholecystectomy Bests Catheter Drainage in High-Risk Cholecystitis Laparoscopic Cholecystectomy Bests Catheter Drainage in High-Risk Cholecystitis
Laparoscopic cholecystectomy is superior to percutaneous catheter drainage in treating acute calculous cholecystitis in high-risk patients - that is, those with APACHE II scores of 7 or more - according to a new clinical trial from the Netherlands.Reuters Health Information (Source: Medscape General Surgery Headlines)
Source: Medscape General Surgery Headlines - October 30, 2018 Category: Surgery Tags: Gastroenterology News Source Type: news

Medical News Today: What to know about laparoscopy for infertility
Laparoscopy is a minimally invasive procedure doctors use to diagnose a variety of conditions, including some that can cause infertility. Learn more here. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - October 30, 2018 Category: Consumer Health News Tags: Fertility Source Type: news

Precision Optics raises $2m
Precision Optics has raised $2 million in a new round of equity financing, according to a recently filed SEC posting. Precision Optics develops optical components for multiple fields, including the medtech industry. The Garner, Mass.-based company develops and manufactures optical and mechanical-optical components, sub-assemblies and systems including lenses, prisms, thin film coatings, optical assemblies, sinuscopes, arthroscopes, laparoscopes, stereo-endoscopes, beamsplitters, endocouplers, camera adapters and fiber optic assemblies, according to its website. The round was joined by five anonymous investors, with the fir...
Source: Mass Device - October 29, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Wall Street Beat Precision Optics Corp. Source Type: news

Olympus launches Endoeye Flex 3D, FlexDex needle driver in US
Olympus (TYO:7733) said yesterday it launched the Endoeye Flex 3D and FlexDex needle driver laparoscopic surgical tools in the U.S. The company said that it is the exclusive distributor for DexFlex in the US, and is combining the Endoeye Flex 3D tech with FlexDex’s wristed needle-driver to improve minimal access surgery procedures. The device can be used during multiple procedure types including general and gynecological specialties. “Olympus and FlexDex are redefining minimal access surgery in the OR. We expect this solution to offer surgeons the precision and control they desire without the burden o...
Source: Mass Device - October 19, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Surgical Olympus Source Type: news

Olympus 3D/FlexDex(R) for Minimal Access Surgery Simplifies Suturing, Redefines Robotics
Powerful Pairing of ENDOEYE FLEX 3D and FlexDex Needle Driver to Be Demonstrated at American College of Surgeons Clinical Conference CENTER VALLEY, Pa., Oct. 18, 2018 -- (Healthcare Sales & Marketing Network) -- Olympus, a global technology leader in d... Devices, Surgery, Product Launch Olympus Medical Systems, 3D/FlexDex, laparoscopic, robotic surgery (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - October 18, 2018 Category: Pharmaceuticals Source Type: news

More Biliary Disease With Laparoscopic Bariatric Surgery More Biliary Disease With Laparoscopic Bariatric Surgery
The move toward laparoscopic bariatric surgery and the decline in bariatric surgery with concomitant cholecystectomy has led to an increase in gallstone-related complications, new research shows.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - October 11, 2018 Category: Consumer Health News Tags: Gastroenterology News Source Type: news

TransEnterix wins FDA nod for 3mm instrument set
TransEnterix (NYSE:TRXC) said today that it won 510(k) clearance from the FDA for a 3mm-diameter instrument set for its Senhance robot-assisted surgery device. The federal safety watchdog also OK’d additional 5mm-diameter instruments, the Research Triangle Park, N.C.-based company said. The 3mm instrument open up micro-laparoscopic “virtually scarless” procedures for Senhance, according to TransEnterix. “The ability to perform microlaparoscopic procedures using 3-millimeter instruments represents an unparalleled shift in the world of robotic surgery and a capability exclusive to the Senhance sy...
Source: Mass Device - October 11, 2018 Category: Medical Devices Authors: Brad Perriello Tags: Featured Food & Drug Administration (FDA) Regulatory/Compliance Robotics Surgical TransEnterix Source Type: news

Does Less-Invasive Surgery Make Sense for You?
WEDNESDAY, Oct. 3, 2018 -- Among the most significant advances in surgery has been the development of laparoscopic -- or minimally invasive -- procedures. These are new ways to perform many standard operations, with a few, very small incisions,... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - October 3, 2018 Category: General Medicine Source Type: news

Laparoscopic Lavage vs Resection for Perforated Diverticulitis Laparoscopic Lavage vs Resection for Perforated Diverticulitis
Dr Lowenfels comments on a study that compares DILALA (DIverticulitis -- LAparoscopic Lavage) versus resection (Hartmann procedure) for perforated diverticulitis.Medscape General Surgery (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - September 26, 2018 Category: Consumer Health News Tags: General Surgery Viewpoint Source Type: news

Monitoring serum Albumin can help patients recover from gastrectomy
(Bentham Science Publishers) Our result suggests preoperative albumin level as an independent risk factor for PPCs in elderly gastric cancer (GC) patients after elective laparoscopic gastrectomy. We also suggest that those elderly hypoalbuminemic GC patients may benefit from more intensive perioperative care including perioperative nutritional status improvement. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - September 18, 2018 Category: International Medicine & Public Health Source Type: news

Better Perioperative Outcomes With Laparoscopic Pancreatoduodenectomy Better Perioperative Outcomes With Laparoscopic Pancreatoduodenectomy
Laparoscopic pancreatoduodenectomy leads to shorter hospital stays and more favorable postoperative course than open pancreatoduodenectomy, according to results from the PADULAP randomized controlled trial.Reuters Health Information (Source: Medscape General Surgery Headlines)
Source: Medscape General Surgery Headlines - September 10, 2018 Category: Surgery Tags: General Surgery News Source Type: news

Robot-Assisted Implantation of Artificial Urinary Sphincter Feasible in Women Robot-Assisted Implantation of Artificial Urinary Sphincter Feasible in Women
Robot assistance helps make laparoscopic implantation of the AMS-800 artificial urinary sphincter (AUS) from Boston Scientific a practical approach to treating women with stress urinary incontinence, according to French researchers.Reuters Health Information (Source: Medscape General Surgery Headlines)
Source: Medscape General Surgery Headlines - September 6, 2018 Category: Surgery Tags: Urology News Source Type: news

TransEnterix submits FDA clearance bid for Senhance ultrasonic instrumentation
TransEnterix (NYSE:TRXC) said today it filed an FDA 510(k) submission for its Senhance Ultrasonic instrument system, designed to operate with its Senhance robotic platform. The Research Triangle Park, N.C.-based company said that the approval would allow the system to utilize ultrasonic devices designed to deliver controlled energy to ligate and divide tissue and minimize thermal injury to the surrounding structures. “Advanced energy devices, such as the one now developed for Senhance, represent the most common tools that surgeons utilize when performing challenging tissue dissections. Adding such capability to ...
Source: Mass Device - September 6, 2018 Category: Medical Devices Authors: Fink Densford Tags: 510(k) Food & Drug Administration (FDA) Regulatory/Compliance Robotics Surgical TransEnterix Source Type: news

Opioid Choice and Postop Recovery After Laparoscopic Surgery Opioid Choice and Postop Recovery After Laparoscopic Surgery
Does the choice of opioids during surgery affect a patient's postoperative quality of recovery?BMC Anesthesiology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - August 29, 2018 Category: Consumer Health News Tags: Anesthesiology Journal Article Source Type: news

Netflix ’ s ‘ The Bleeding Edge ’ raises big questions for medical device manufacturers
Sandra Maddock, president and CEO, IMARC Research Thanks in large part to innovation in the medical device industry, the average human lifespan has nearly doubled in the past hundred years. Medical devices have undoubtedly improved the quality of life for millions of people, too. But a provocative new Netflix documentary raises an important question: Is there a point when innovation goes too far? The Bleeding Edge, produced by Academy-Award nominated filmmakers Kirby Dick and Amy Ziering, tells the stories of patients who say they’ve suffered serious health problems as a result of recent medical devices being used ...
Source: Mass Device - August 24, 2018 Category: Medical Devices Authors: Danielle Kirsh Tags: Blog IMARC Source Type: news

Olympus and FlexDex take aim at big, expensive robots
  FlexDex Surgical’s Needle Driver Olympus has signed an agreement with FlexDex Surgical to compete with full-blown robotics systems designed for minimally invasive procedures, the companies said today. Olympus agreed to distribute FlexDex’s (Brighton, Mich.) wrist-worn Needle Driver robotic device designed to simplify suturing in difficult-to-reach areas of the abdomen. Needle Driver has a three-axis gimbal that attaches to the surgeon’s wrist to control a series of mechanical components that translate the movement of the surgeon’s hand to the tip of the instrument, ac...
Source: Mass Device - August 23, 2018 Category: Medical Devices Authors: Nancy Crotti Tags: Blog Business/Financial News Distribution Imaging Robotics FlexDex Surgical Olympus Source Type: news

Big Strides in Miniaturization
MD+DI has been tracking miniaturization for some time, as we’ve seen trends deepen in minimally invasive surgeries, wearable devices, advanced drug delivery, and more. Lindsay Mann, director of marketing for MTD Micro Molding, tells MD+DI that about 25% of the micro medical device components they produce are for miniaturized devices. We asked her for an update on miniaturization, including recent advancements in materials and manufacturing.   What is driving the current trend toward medical device miniaturization? Mann: As less invasive procedures and technology-driven advancements...
Source: MDDI - August 8, 2018 Category: Medical Devices Authors: Daphne Allen Tags: MD & M Minneapolis Molding Source Type: news

From sharks to chimps to moon bears: tales of a supervet
Romain Pizzi, who pioneered keyhole surgery for animals, is arguably the most versatile and inventive vet in the worldIn 2012, the conservation charityFree the Bears approachedRomain Pizzi, one of the most innovative wildlife surgeons in Europe, with an unusual patient. A specialist in laparoscopic (keyhole) surgery – until recently rare in veterinary medicine – Pizzi has operated on giraffes and tarantulas, penguins and baboons, giant tortoises and at least one shark, and maintains a reputation for taking on cases others won’t. If you’re in possession of a tiger with gallstones, or a suspiciously s...
Source: Guardian Unlimited Science - August 5, 2018 Category: Science Authors: Oliver Franklin-Wallis Tags: Animals Animal welfare Source Type: news

VisCardia heart failure implant study underway in Ukraine
VisCardia’s implantable VisOne diaphragm stimulator Novel heart failure device developer VisCardia, Inc. (Portland, Ore.) announced the first implant of the VisONE system for heart failure and the launch of the system’s heart failure pilot study in Ukraine. The VisONE implantable system delivers asymptomatic diaphragmatic stimulation (ADS) therapy to improve cardiac function. A surgeon laparoscopically implants a medical device equipped with electrodes to deliver electrical pulses to precise areas of the diaphragm. The electrically stimulated diaphragm applies transient intrathoracic pressur...
Source: Mass Device - August 2, 2018 Category: Medical Devices Authors: Nancy Crotti Tags: Blog Source Type: news

Do You Know How to Manage Japan ’s Revised Reimbursement Approach?
One significant change in Japan’s revised reimbursement process for new medical devices involves pricing. Applicants have been required for some time to provide pricing for their medical devices in other primary markets such as the United States, the United Kingdom, Germany, France, and Australia. Pricing has been based on list price, not market price, and the intention was to cap the reimbursement of medical devices. Given the typical differences between U.S. pricing and European pricing, the high U.S. price tended to pull the average up. (Please see the example below in Table 1; each price is converted ...
Source: MDDI - July 27, 2018 Category: Medical Devices Authors: Keisuke Suzuki Tags: Regulatory and Compliance Source Type: news

Tanzania:Men With Prostate Issues Have a Reason to Smile As Mkapa Hospital Goes High-Tech
[Citizen] Dodoma -For men with prostate complications, there is a reason to smile as the Dodoma-based Benjamin Mkapa Hospital (BMH) embarks on provision of laparoscopic surgical services. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - July 27, 2018 Category: African Health Source Type: news